Stay updated with breaking news from Ring Sideroblasts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hematologist-oncologists address adverse event management and discuss the unmet needs of patients with lower-risk MDS and symptomatic anemia.
The expert panel provides comprehensive insights on another patient case, a 77-year-old with MDS who presented with symptomatic anemia.
In the second article of this series, Abdulraheem Yacoub, MD, discusses recent updates from the IMerge clinical trial, which is studying imetelstat in patients with low-risk MDS.
The comprehensive industry research on Multiple Endocrine Neoplasia Treatment Market published by Data Bridge Market research which includes growth analysis,
Discoveries & Impact highlights select scientific discoveries across the Department of Internal Medicine...